Division of Infectious Diseases & Immunology

At NYU Langone Health’s Division of Infectious Diseases and Immunology, our mission is to be a local and global center of excellence in patient care, education and training, research, and leadership within the field.
Our experts provide outstanding care to patients and offer comprehensive clinical and research training in infectious diseases and immunology to fellows, residents, and medical students. We also advance research in basic science, clinical studies and clinical trials, epidemiology, health services, and issues such as vaccine hesitancy.
Led by director Mark J. Mulligan, MD, the Thomas S. Murphy Sr. Professor in the Department of Medicine, professor in the Department of Microbiology, and director of NYU Langone’s Vaccine Center, our division includes a dynamic group of faculty. We launched the Vaccine Center in 2018 with the goal of preventing the spread of diseases by merging vaccine research with basic science, clinical studies, and public health outreach.
Our faculty’s award-winning physician–educators and physician–scientists provide clinical services in different locations at NYU Langone. Our five inpatient locations in Manhattan and Brooklyn are Tisch Hospital, Kimmel Pavilion, NYU Langone Orthopedic Hospital, Hassenfeld Children’s Hospital at NYU Langone, and NYU Langone Hospital—Brooklyn. We are also affiliated with NYC Health + Hospitals/Bellevue and the VA NY Harbor Healthcare System. This helps us provide an unparalleled breadth and depth of clinical and research experiences to our trainees and junior faculty.
Through our work to research, prevent, and treat infectious diseases, allergies, and immunologic disorders, we aim to protect and restore the health of our patients and communities.
Infectious Diseases Specialist Discusses Spread of COVID-19 in the United States
Watch More
Infectious Diseases and Immunology Fellowship

Clinical Services

Research

Vaccine Center

Related News

The Race for a COVID-19 Vaccine Begins Here

NYU Langone Doctor Joins Joe Biden’s COVID-19 Advisory Board

NYU Langone to Enroll Volunteers in COVID-19 Vaccine Trial

New York Recognize Heroes on COVID-19 Front Lines

Phase 2/3 Clinical Trial for COVID-19 Vaccine Starts

Clinical Trial to Study Antibody Treatment Against COVID-19

What You Need to Know About Coronavirus

COVID-19 Vaccine Trial Starts

NYU Langone Is Site of Pfizer-Led Coronavirus Vaccine Trials
